Wagenknecht G - Search Results

1

[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding].

Kupferschläger J, Müller B, Schulz G, Kaiser HJ, Wagenknecht G, Bares R, Büll U. Kupferschläger J, et al. Among authors: wagenknecht g. Nuklearmedizin. 1997 Mar;36(2):56-64. Nuklearmedizin. 1997. PMID: 9148274 German.

2

A method of correlating and merging cerebral morphology and function by a special head holder.

Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Büll U. Kaiser HJ, et al. Among authors: wagenknecht g. Nuklearmedizin. 1994 Jun;33(3):123-6. Nuklearmedizin. 1994. PMID: 8090627

3

[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].

Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U. Sabri O, et al. Among authors: wagenknecht g. Nuklearmedizin. 1998 May;37(3):83-9. Nuklearmedizin. 1998. PMID: 9604227 German.

4

[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Tuttass T, Schulz G, Kaiser HJ, Wagenknecht G, Sass H, Büll U. Schreckenberger M, et al. Among authors: wagenknecht g. Nuklearmedizin. 1998;37(8):262-7. Nuklearmedizin. 1998. PMID: 9868707 Clinical Trial. German.

5

One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathy.

Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser HJ, Wagenknecht G, Setani K, Reinartz P, Zimny M, Mull M, Ringelstein EB, Büll U. Sabri O, et al. Among authors: wagenknecht g. Nuklearmedizin. 2000;39(2):43-9. Nuklearmedizin. 2000. PMID: 10768169

6

[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].

Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, Osieka R, Günther R, Büll U. Thill R, et al. Among authors: wagenknecht g. Nuklearmedizin. 1997 Oct;36(7):234-9. Nuklearmedizin. 1997. PMID: 9441282 German.

7

Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucose.

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Schulz G, Tuttass T, Wagenknecht G, Kaiser HJ, Sass H, Buell U. Schreckenberger M, et al. Among authors: wagenknecht g. Eur J Nucl Med. 1998 Nov;25(11):1511-9. doi: 10.1007/s002590050329. Eur J Nucl Med. 1998. PMID: 9799347 Clinical Trial.

8

[The multimodal integration, correlation and fusion of morphology and function: the methods and initial clinical applications].

Wagenknecht G, Kaiser HJ, Büll U. Wagenknecht G, et al. Rofo. 1999 May;170(5):416-26. doi: 10.1055/s-2007-1011068. Rofo. 1999. PMID: 10370404 Review. German.

9

Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow.

Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser HJ, Wagenknecht G, Mull M, Buell U. Sabri O, et al. Among authors: wagenknecht g. Nucl Med Commun. 2000 Jan;21(1):19-29. doi: 10.1097/00006231-200001000-00005. Nucl Med Commun. 2000. PMID: 10717898 Clinical Trial.

10

"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study.

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Zimny M, Zeggel T, Wagenknecht G, Kaiser HJ, Sass H, Buell U. Schreckenberger M, et al. Among authors: wagenknecht g. Eur J Nucl Med. 1999 Dec;26(12):1572-9. doi: 10.1007/s002590050497. Eur J Nucl Med. 1999. PMID: 10638409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters